2 rejected and 48 returned for revision. Most common reasons: Source Evidence Match (3), Doi Exists (1).
Why these were not published
50 decisions · click a reason to filter
Total
50
Jul 28, 2026
ReviseResearch Synthesis: Fasting Intervention Intermittent Fasting If Effects
Living evidence brief
Why: Resolve the duplicate sentences in the Discussion section and produce a clean final render of the long-form manuscript.; Reconcile the outcome-class direction coding between the Findings Map, the Results table, and the Cross-Domain Synthesis so that every source in every slice has a single, traceable direction code that the rest of the paper cites consistent...
Jul 28, 2026
ReviseResearch Synthesis: Fasting Intervention Intermittent Fasting If Effects
Living evidence brief
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 9/24 claims are exactly traceable (required 20).
Jul 28, 2026
ReviseResearch Synthesis: Resveratrol Intervention Resveratrol Supplementation Subgroups
Living evidence brief
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 8/24 claims are exactly traceable (required 20).
Jul 28, 2026
ReviseResearch Synthesis: Fasting Intervention Intermittent Fasting If Effects
Living evidence brief
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 5/20 claims are exactly traceable (required 16).
Why: Source Evidence Match
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 10/30 claims are exactly traceable (required 24).
Why: Researka gate decision: revise.
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 17/30 claims are exactly traceable (required 24).
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 17/30 claims are exactly traceable (required 24).
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 10/30 claims are exactly traceable (required 24).
Why: Replace all 'a source-reported estimate' and empty p-value placeholders with the actual numeric values (or, if not present in the bundle, omit the numeric and explicitly state that the source excerpt does not include the value).; Reconcile the Tavabi 2021, Espinoza 2022, Maio 2026, and Orchard 2021 direction codes against the actual bundle excerpts before re...
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 23/30 claims are exactly traceable (required 24).
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 23/30 claims are exactly traceable (required 24).
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 23/30 claims are exactly traceable (required 24).
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 23/30 claims are exactly traceable (required 24).
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 20/30 claims are exactly traceable (required 24).
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 20/30 claims are exactly traceable (required 24).
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 20/30 claims are exactly traceable (required 24).
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 17/30 claims are exactly traceable (required 24).
Why: Remove or bundle-trace every exact statistic in the manuscript Results and Cross-Domain Synthesis
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 21/30 claims are exactly traceable (required 24).
Jul 27, 2026
ReviseResearch Synthesis: Metformin Intervention Metformin Treatment Effects
Living evidence brief
Why: Reconcile the Methods funnel arithmetic so the admitted-source count and classified-candidate count are consistent; either report actual candidate counts or remove the funnel numbers and state the corpus size directly.; Resolve the contradiction between 'no mechanistic sources' (Abstract) and '18/33 indirect, review-level, adjacent, or mechanistic' (Abstract...
Why: Reconcile the immune outcome class internally: either describe Schiapaccassa 2019 as concordant anti-inflammatory direction across endpoints (matching the Results paragraph) and remove 'mixed' from the Findings Map direction, or describe the class as heterogeneous with mixed findings
Why: Add exact source tokens, DOI/PMID links, or evidence spans to major claims; 12/25 claims are exactly traceable (required 20).
Page 1 of 3